Literature DB >> 17131359

Mitochondrial ribosomal protein S36 delays cell cycle progression in association with p53 modification and p21(WAF1/CIP1) expression.

Yeong-Chang Chen1, Meng-Ya Chang, Ai-Li Shiau, Yi-Te Yo, Chao-Liang Wu.   

Abstract

Ribosomal biogenesis is correlated with cell cycle, cell proliferation, cell growth and tumorigenesis. Some oncogenes and tumor suppressors are involved in regulating the formation of mature ribosome and affecting the ribosomal biogenesis. In previous studies, the mitochondrial ribosomal protein L41 was reported to be involved in cell proliferation regulating through p21(WAF1/CIP1) and p53 pathway. In this report, we have identified a mitochondrial ribosomal protein S36 (mMRPS36), which is localized in the mitochondria, and demonstrated that overexpression of mMRPS36 in cells retards the cell proliferation and delays cell cycle progression. In addition, the mMRPS36 overexpression induces p21(WAF1/CIP1) expression, and regulates the expression and phosphorylation of p53. Our result also indicate that overexpression of mMRPS36 affects the mitochondrial function. These results suggest that mMRPS36 plays an important role in mitochondrial ribosomal biogenesis, which may cause nucleolar stress, thereby leading to cell cycle delay.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17131359     DOI: 10.1002/jcb.21079

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  15 in total

Review 1.  Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications.

Authors:  Wei Wang; Subhasree Nag; Xu Zhang; Ming-Hai Wang; Hui Wang; Jianwei Zhou; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2014-08-28       Impact factor: 12.944

2.  Differential gene expression in pancreatic tissues of streptozocin-induced diabetic rats and genetically-diabetic mice in response to hypoglycemic dipeptide cyclo (His-Pro) treatment.

Authors:  Song Ah Choi; Hyung Joo Suh; Jong Won Yun; Jang Won Choi
Journal:  Mol Biol Rep       Date:  2012-06-17       Impact factor: 2.316

Review 3.  A compendium of human mitochondrial gene expression machinery with links to disease.

Authors:  Timothy E Shutt; Gerald S Shadel
Journal:  Environ Mol Mutagen       Date:  2010-06       Impact factor: 3.216

4.  Expression and prognosis analysis of mitochondrial ribosomal protein family in breast cancer.

Authors:  Xiaoyi Lin; Lijuan Guo; Xin Lin; Yulei Wang; Guochun Zhang
Journal:  Sci Rep       Date:  2022-06-23       Impact factor: 4.996

5.  The effect of mutated mitochondrial ribosomal proteins S16 and S22 on the assembly of the small and large ribosomal subunits in human mitochondria.

Authors:  Md Emdadul Haque; Domenick Grasso; Chaya Miller; Linda L Spremulli; Ann Saada
Journal:  Mitochondrion       Date:  2008-04-30       Impact factor: 4.160

6.  LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation.

Authors:  Kaixuan Zeng; Xiaoxiang Chen; Xiuxiu Hu; Xiangxiang Liu; Tao Xu; Huiling Sun; Yuqin Pan; Bangshun He; Shukui Wang
Journal:  Oncogene       Date:  2018-06-13       Impact factor: 9.867

7.  Bot1p is required for mitochondrial translation, respiratory function, and normal cell morphology in the fission yeast Schizosaccharomyces pombe.

Authors:  David J Wiley; Paola Catanuto; Flavia Fontanesi; Carmen Rios; Natalie Sanchez; Antoni Barrientos; Fulvia Verde
Journal:  Eukaryot Cell       Date:  2008-02-01

8.  Down-regulation of MRPS23 inhibits rat breast cancer proliferation and metastasis.

Authors:  Yan Gao; Fuyan Li; Hong Zhou; Yi Yang; Ruimin Wu; Yijia Chen; Wei Li; Yang Li; Xueqin Xu; Changbin Ke; Zhijun Pei
Journal:  Oncotarget       Date:  2017-05-15

Review 9.  Ribosome Biogenesis and Cancer: Overview on Ribosomal Proteins.

Authors:  Annalisa Pecoraro; Martina Pagano; Giulia Russo; Annapina Russo
Journal:  Int J Mol Sci       Date:  2021-05-23       Impact factor: 5.923

10.  Sorbin and SH3 domain-containing protein 2 is released from infarcted heart in the very early phase: proteomic analysis of cardiac tissues from patients.

Authors:  Yu Kakimoto; Shinji Ito; Hitoshi Abiru; Hirokazu Kotani; Munetaka Ozeki; Keiji Tamaki; Tatsuaki Tsuruyama
Journal:  J Am Heart Assoc       Date:  2013-12-16       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.